US Broker Ratings

Premier, Inc. (PINC) Investor Outlook: Navigating Flat Prices and Dividend Opportunities

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, represents a unique investment case for those eyeing the health information services industry. With..

Enovis Corporation (ENOV): Investor Outlook Reveals 83% Potential Upside in the Medical Device Sector

Enovis Corporation (NYSE: ENOV), a notable player in the healthcare sector, specifically within the medical devices industry, presents a compelling case for individual investors. With a..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating Growth with a 15.7% Revenue Surge

LeMaitre Vascular, Inc. (LMAT), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, has been catching the eyes of investors..

Alignment Healthcare, Inc. (ALHC) Investor Outlook: Analyzing a 39.96% Potential Upside

For investors seeking opportunities in the healthcare sector, Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing proposition. With a market capitalization of $3.72 billion, this Orange,..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 49% Potential Upside

Clover Health Investments, Corp (NASDAQ: CLOV) presents an intriguing opportunity for investors looking into the healthcare sector, with a significant potential upside of 49.17%. As a..

Evotec SE (EVO) Stock Analysis: Exploring the 82.75% Potential Upside for Strategic Investors

For investors seeking opportunities within the healthcare sector, Evotec SE (NASDAQ: EVO) presents a compelling, if complex, case. As a drug discovery and development company, Evotec..

Mesoblast Limited (MESO) Stock Analysis: Unveiling a Potential 126.83% Upside

Investors eyeing opportunities within the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) particularly intriguing. This Australian healthcare entity, with a market capitalization of $2.05 billion,..

NovoCure Limited (NVCR) Stock Analysis: Can its Tumor Treating Innovations Drive a 100% Upside?

NovoCure Limited (NASDAQ: NVCR), a pioneering healthcare company in the medical devices sector, has captured significant investor attention with its innovative approach to cancer treatment. Specializing..

Ascentage Pharma (AAPG) Stock Analysis: Uncovering a 108% Upside Potential in Biotech Innovations

Ascentage Pharma Group International (NASDAQ: AAPG), a pioneering force in the biotechnology sector, is gaining traction with investors due to its robust pipeline of innovative therapies..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 40.77% Potential Upside in the Biotech Sector

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a pioneering force in the biotechnology sector, has captured the attention of investors with its innovative approach to drug development. As..

Phreesia, Inc. (PHR) Stock Analysis: Is the 132% Potential Upside Worth the Investment?

Phreesia, Inc. (PHR) is carving a niche within the healthcare sector as a provider of integrated SaaS-based software and payment platforms. Operating primarily in the United..

Immunocore Holdings (IMCR) Stock Analysis: Exploring a 94.59% Potential Upside in the Biotech Arena

Investors with a keen eye on the biotechnology sector should not overlook Immunocore Holdings plc (NASDAQ: IMCR), a promising player in the healthcare industry with a..

LifeStance Health Group, Inc. (LFST) Investor Outlook: Exploring a 42% Potential Upside in Mental Health Services

LifeStance Health Group, Inc. (LFST), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on mental health services across the..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A 41% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) is making waves in the biotechnology sector with its promising pipeline of novel biologics aimed at treating a range of inflammatory..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 68% Potential Upside in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC), a notable player in the healthcare sector, stands out as an intriguing opportunity for investors with its robust product portfolio and promising..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Investors Eye Nearly 89% Potential Upside with Strong Buy Ratings

Alphatec Holdings, Inc. (ATEC), a key player in the medical devices sector, is capturing investor attention with its innovative approach to spinal disorder treatments and a..

Centessa Pharmaceuticals (CNTA): Exploring a 51.95% Potential Upside in the Biotech Sector

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is making waves in the biotechnology industry with its innovative approach to drug development. Headquartered in Altrincham, United Kingdom, Centessa is..

Travere Therapeutics, Inc. (TVTX) Investor Outlook: A 47% Potential Upside Beckons

For investors with a penchant for the healthcare sector, particularly in the biotechnology industry, Travere Therapeutics, Inc. (TVTX) presents an intriguing opportunity. As a biopharmaceutical company..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 16.61% Potential Upside Awaits Investors

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector specializing in the development and commercialization of treatments for central nervous system (CNS) diseases,..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking the 37% Potential Upside

Haemonetics Corporation (NYSE: HAE), a stalwart in the healthcare sector, specifically within the medical devices industry, is drawing investor attention with its compelling growth potential. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds